Neurogenesis deficits in Down syndrome: testing recovery with GABA alpha 5 negative allosteric modulator, beta 2 adrenergic agonist and IGF-1 in Ts65Dn mice.

C Albac, F Stagni, Mariagrazia GRILLI, ME Salvalai, R Bartesaghi, MC Potier

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S445-S446
JournalEuropean Neuropsychopharmacology
Volume29
Publication statusPublished - 1 Jan 2019

Cite this